Frontiers in Endocrinology (Feb 2024)

Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial

  • Madhukar Mittal,
  • Azher Rizvi

DOI
https://doi.org/10.3389/fendo.2024.1342915
Journal volume & issue
Vol. 15

Abstract

Read online

No abstracts available.

Keywords